为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

帕比司他

规格或纯度: ≥98%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
P125167-10mg
10mg 现货 Stock Image
P125167-50mg
50mg 现货 Stock Image
P125167-100mg
100mg 现货 Stock Image
P125167-250mg
250mg 现货 Stock Image

基本描述

别名 帕比司他
英文别名 BCP01816|Panobinostat(LBH589)|AM808102|GTPL7489|NSC 108217|AKOS005146046|N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide|EX-A169|NVP-LBH 589|1-Brom-4-methansulfonylbenzen|EN300-7395075|LBH-589B|NVP-LBH589|NVP-LBH-589|(E
规格或纯度 ≥98%
英文名称 Panobinostat (LBH589)
生化机理 Panobinostat (LBH589) is a HDAC (histone deactylase) inhibitor of research interest for multiple diseases such as multiple myeloma. The deacetylation of histones is associated with transcriptional silencing. Panobinostat was reported to inhibit several human multiple myeloma cell lines with and IC50 ≥ 20nM. Panobinostat was also reported to induce expression of DNA damage response genes and induce apoptosis in Ph- acute lymphoblastic leukemia cells.
应用 An HDAC inhibitor reported to inhibit human multiple myeloma cell lines.
储存温度 -20°C储存
运输条件 超低温冰袋运输
产品介绍

Panobinostat (LBH589)是一种新型的,广谱的HDAC抑制剂,IC50为5 nM。Phase 3。An HDAC inhibitor reported to inhibit human multiple myeloma cell lines.

Panobinostat (LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM. Phase 3.
An HDAC inhibitor reported to inhibit human multiple myeloma cell lines.

名称和标识符

PubChem SID 488195886
IUPAC Name (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide
INCHI InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/b11-10+
InChi Key FPOHNWQLNRZRFC-ZHACJKMWSA-N
Canonical SMILES CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO
Isomeric SMILES CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO
PubChem CID 6918837
分子量 349.44

化学和物理性质

溶解性 Soluble in DMSO (70 mg/ml), methanol, water (<1.2 mg/ml), DMF (~50 mg/ml), and ethanol (~3.3 mg/ml).

安全和危险性(GHS)

象形图
ghs06

Toxic

ghs08

Health Hazard

ghs05

Corrosive

ghs07

Harmful

信号词 Danger
危险声明 H315: Causes skin irritation
H301: Toxic if swallowed
H331: Toxic if inhaled
H373: Causes damage to organs through prolonged or repeated exposure
H318: Causes serious eye damage
H360: May damage fertility or the unborn child
H301+H331: Toxic if swallowed or if inhaled
预防措施声明 P261,P280,P302+P352,P321,P405,P501,P264,P260,P271,P270,P304+P340,P403+P233,P362+P364,P330,P203,P264+P265,P301+P316,P305+P354+P338,P318,P317,P332+P317,P316,P319

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Mack GS.  (2010)  To selectivity and beyond..  Nat Biotechnol,  28  (12):  (1259-66).  [PMID:21139608]
2. Engel JA, Jones AJ, Avery VM, Sumanadasa SD, Ng SS, Fairlie DP, Skinner-Adams T, Andrews KT.  (2015)  Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites..  Int J Parasitol Drugs Drug Resist,  (3):  (117-26).  [PMID:26199860]
3. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N et al..  (2008)  Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors..  Biochem J,  409  (2):  (581-9).  [PMID:17868033]